Evidence map›Paper›PMID 22138156›Full record

ArticleNeuroscience2012

Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic-pituitary-adrenal axis responses in male Sprague-Dawley rats.

R J Newsom, C Osterlund, C V Masini, H E Day, R L Spencer, S Campeau

Abstract read
In one paragraph

Article in Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Endocannabinoids in Body Weight Control.Pharmaceuticals (Basel, Switzerland) · 2018
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Neurobiological Interactions Between Stress and the Endocannabinoid System.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Review
  15. Review
  16. Article
  17. Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  18. Endocannabinoids and the Endocrine System in Health and Disease.Handbook of experimental pharmacology · 2015
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

R J NewsomDepartment of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA.
C Osterlund
C V Masini
H E Day
R L Spencer
S Campeau
University of Colorado Boulder · US

Funding

Glucocorticoid Negative Feedback: Intrinsic and Extrinsic MechanismsR01MH075968 · NIMH · UNIVERSITY OF COLORADO · PI SPENCER, ROBERT L · 2006 to 2012
$2.0M
Habituation of Repeated StressR01MH077152 · NIMH · UNIVERSITY OF COLORADO · PI CAMPEAU, SERGE · 2008 to 2012
$1.6M
NIMH NIH HHS R01 MH075968NIMH NIH HHS R01 MH077152
6 · The paper itself

Abstract

Altered regulation of the hypothalamic-pituitary-adrenal (HPA) axis is associated with stress-induced changes in cognitive, emotional, and physical health. Recent evidence indicates that the endogenous cannabinoid (eCB) system may modulate HPA-axis function both directly and more centrally, via regulation of limbic brain systems that control HPA-axis activity. The current study examines the contribution of cannabinoid type 1 (CB1) receptor modulation throughout the neuraxis on control and stress-induced HPA-axis activity. Adult male Sprague-Dawley rats were given intraperitoneal injections of either CB1 receptor antagonist (AM251, 2 mg/kg) or vehicle 30 min prior to a session of loud white noise stress (95 dBA for 30 min) or placement in a familiar sound-proof chamber. Immediately following stress and control treatments, rats were killed, the brains and pituitary glands were excised for subsequent immediate early gene (c-fos mRNA) measurement, and trunk blood was collected for subsequent determination of corticosterone (CORT) and adrenocorticotropic (ACTH) hormone levels. AM251 treatment resulted in a potentiated plasma ACTH response to loud noise stress. AM251 treatment also increased stress-induced plasma CORT levels, but that increase may be due to an increase in basal plasma CORT levels, as was evident in control rats. AM251 treatment produced three distinctive c-fos mRNA response patterns across the various brain regions examined. In cortical (prelimbic, infralimbic, somatosensory, and auditory) and some subcortical structures (basolateral amygdala and paraventricular nucleus of the hypothalamus), AM251 treatment produced a substantial increase in c-fos mRNA that was comparable with the elevated c-fos mRNA levels present in those brain regions of both vehicle and AM251-treated stressed rats. In some other subcortical structures (bed nucleus of the stria terminalis and medial preoptic area) and the anterior pituitary, AM251 treatment produced a c-fos mRNA response pattern that was similar to the response pattern of ACTH hormone levels, that is, no effect on no noise control levels, but an augmentation of stress-induced levels. Conversely, in the medial geniculate and ventral posterior thalamus, AM251 treatment inhibited stress-induced c-fos mRNA induction. These data indicate that disruption of eCB signaling through CB1 receptors results in potentiated neural and endocrine responses to loud noise stress, but also substantial increases in activity in various brain regions and the adrenal gland.

Indexed as

Adrenocorticotropic HormoneAnimalsCorticosteroneHypothalamo-Hypophyseal SystemMaleNeuronsNoisePiperidinesPituitary-Adrenal SystemProto-Oncogene Proteins c-fosPyrazolesRatsRats, Sprague-DawleyReceptor, Cannabinoid, CB1Stress, PhysiologicalAdrenocorticotropic HormoneAM 251CorticosteronePiperidinesProto-Oncogene Proteins c-fosPyrazolesReceptor, Cannabinoid, CB1

Identifiers

PMID22138156
PMCPMC3288505
OpenAlexW1998894486

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.